It looks like you normalized price of SC6 US$1359/t - I suppose this your forward price curve. I have seen other npv valuations on the forum and they simply project US$4,000/t flat and get much higher valuations. I think what your analysis has indicated , Leo has a lot upside in peer comparison. I would add that CXO as a company in production is much more derisked - so you should also add risked NPVs to your analysis.. the other point... I don't think factor expansion plans which have not been disclosed.
- Forums
- ASX - By Stock
- CXO
- Banter and general comments
Banter and general comments, page-26416
-
- There are more pages in this discussion • 12,939 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $257.1M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 11.5¢ | $1.522M | 12.63M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 2417772 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 3476810 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 2417772 | 0.120 |
75 | 5968843 | 0.115 |
105 | 5477108 | 0.110 |
65 | 4298051 | 0.105 |
130 | 9813931 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 3446810 | 28 |
0.130 | 3623148 | 36 |
0.135 | 4927324 | 47 |
0.140 | 3192195 | 37 |
0.145 | 1896887 | 28 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online